Influence of robust optimization in intensity-modulated proton therapy with different dose delivery techniques.

PURPOSE The distal edge tracking (DET) technique in intensity-modulated proton therapy (IMPT) allows for high energy efficiency, fast and simple delivery, and simple inverse treatment planning; however, it is highly sensitive to uncertainties. In this study, the authors explored the application of DET in IMPT (IMPT-DET) and conducted robust optimization of IMPT-DET to see if the planning technique's sensitivity to uncertainties was reduced. They also compared conventional and robust optimization of IMPT-DET with three-dimensional IMPT (IMPT-3D) to gain understanding about how plan robustness is achieved. METHODS They compared the robustness of IMPT-DET and IMPT-3D plans to uncertainties by analyzing plans created for a typical prostate cancer case and a base of skull (BOS) cancer case (using data for patients who had undergone proton therapy at our institution). Spots with the highest and second highest energy layers were chosen so that the Bragg peak would be at the distal edge of the targets in IMPT-DET using 36 equally spaced angle beams; in IMPT-3D, 3 beams with angles chosen by a beam angle optimization algorithm were planned. Dose contributions for a number of range and setup uncertainties were calculated, and a worst-case robust optimization was performed. A robust quantification technique was used to evaluate the plans' sensitivity to uncertainties. RESULTS With no uncertainties considered, the DET is less robust to uncertainties than is the 3D method but offers better normal tissue protection. With robust optimization to account for range and setup uncertainties, robust optimization can improve the robustness of IMPT plans to uncertainties; however, our findings show the extent of improvement varies. CONCLUSIONS IMPT's sensitivity to uncertainties can be improved by using robust optimization. They found two possible mechanisms that made improvements possible: (1) a localized single-field uniform dose distribution (LSFUD) mechanism, in which the optimization algorithm attempts to produce a single-field uniform dose distribution while minimizing the patching field as much as possible; and (2) perturbed dose distribution, which follows the change in anatomical geometry. Multiple-instance optimization has more knowledge of the influence matrices; this greater knowledge improves IMPT plans' ability to retain robustness despite the presence of uncertainties.

[1]  A. Lomax,et al.  Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties , 2008, Physics in medicine and biology.

[2]  Radhe Mohan,et al.  Robust optimization of intensity modulated proton therapy. , 2012, Medical physics.

[3]  Matthias Fippel,et al.  A pencil beam algorithm for intensity modulated proton therapy derived from Monte Carlo simulations , 2005, Physics in medicine and biology.

[4]  Timothy C Y Chan,et al.  Accounting for range uncertainties in the optimization of intensity modulated proton therapy , 2007, Physics in medicine and biology.

[5]  Gudrun Goitein,et al.  The clinical potential of intensity modulated proton therapy. , 2004, Zeitschrift fur medizinische Physik.

[6]  Thomas Bortfeld,et al.  Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning. , 2008, Medical physics.

[7]  Wei Chen,et al.  Including robustness in multi-criteria optimization for intensity-modulated proton therapy , 2011, Physics in medicine and biology.

[8]  A J Lomax,et al.  Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions , 2008, Physics in medicine and biology.

[9]  Wei Liu,et al.  Parameterization of multiple Bragg curves for scanning proton beams using simultaneous fitting of multiple curves , 2011, Physics in medicine and biology.

[10]  Francesca Albertini,et al.  In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453). , 2007, International journal of radiation oncology, biology, physics.

[11]  M. Schwarz,et al.  Treatment planning in proton therapy , 2011 .

[12]  A Brahme,et al.  Optimization of proton and heavy ion therapy using an adaptive inversion algorithm. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  A. Lomax,et al.  Is it necessary to plan with safety margins for actively scanned proton therapy? , 2011, Physics in medicine and biology.

[14]  T R Mackie,et al.  A compact linac for intensity modulated proton therapy based on a dielectric wall accelerator. , 2008, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[15]  Uwe Oelfke,et al.  Inverse planning of intensity modulated proton therapy. , 2004, Zeitschrift fur medizinische Physik.

[16]  A. Lomax,et al.  Intensity modulation methods for proton radiotherapy. , 1999, Physics in medicine and biology.

[17]  Thomas Bortfeld,et al.  Evaluation of Dosimetric Gain and Uncertainties in Proton Therapy Delivery with Scanned Pencil Beam in Treatment of Base-of-skull and Spinal Tumors , 2010 .

[18]  Michael Gillin,et al.  Spot scanning proton beam therapy for prostate cancer: treatment planning technique and analysis of consequences of rotational and translational alignment errors. , 2010, International journal of radiation oncology, biology, physics.

[19]  J. Balter,et al.  Evaluation of multiple breathing states using a multiple instance geometry approximation (MIGA) in inverse-planned optimization for locoregional breast treatment. , 2008, International journal of radiation oncology, biology, physics.

[20]  E. Pedroni,et al.  Intensity modulated proton therapy: a clinical example. , 2001, Medical physics.

[21]  A. Lomax,et al.  The influence of the optimization starting conditions on the robustness of intensity-modulated proton therapy plans , 2010, Physics in medicine and biology.

[22]  R Mohan,et al.  Algorithms and functionality of an intensity modulated radiotherapy optimization system. , 2000, Medical physics.

[23]  Anders Forsgren,et al.  Minimax optimization for handling range and setup uncertainties in proton therapy. , 2011, Medical physics.

[24]  T. Bortfeld,et al.  Inverse planning for photon and proton beams. , 2001, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[25]  Radhe Mohan,et al.  An efficient dose calculation strategy for intensity modulated proton therapy. , 2011, Physics in medicine and biology.

[26]  M Goitein,et al.  A pencil beam algorithm for proton dose calculations. , 1996, Physics in medicine and biology.

[27]  Gino J. Lim,et al.  A two-phase method for selecting IMRT treatment beam angles: Branch-and-Prune and local neighborhood search , 2012, Eur. J. Oper. Res..

[28]  Wei Liu,et al.  TH‐C‐BRB‐01: Toward a thorough Evaluation of IMPT Plan Sensitivity to Uncertainties: Revisit the Worst‐Case Analysis with An Exhaustively Sampling Approach , 2011 .

[29]  Thomas Bortfeld,et al.  Range, Setup and Dose Calculation Errors in IMPT and Their Interrelation , 2009 .

[30]  U Oelfke,et al.  Worst case optimization: a method to account for uncertainties in the optimization of intensity modulated proton therapy , 2008, Physics in medicine and biology.

[31]  Joe Y. Chang,et al.  4D Proton treatment planning strategy for mobile lung tumors. , 2007, International journal of radiation oncology, biology, physics.

[32]  T Bortfeld,et al.  An analytical approximation of the Bragg curve for therapeutic proton beams. , 1997, Medical physics.

[33]  Radhe Mohan,et al.  Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study. , 2010, International journal of radiation oncology, biology, physics.